OrbusNeich Medical Group Holdings Limited (6929.HK) has a MoatMap StockRank of 82/100 based on Quality (73/100), Value (47/100), and Momentum (45/100) factor scores. The current signal is STRONG BUY. OrbusNeich is a specialized medical device company focusing on balloon catheters. While it has decent gross margins, it lacks a dominant global moat and does not fit into our high-conviction macro themes.
OrbusNeich Medical Group Holdings Limited is a global medical device manufacturer specializing in interventional instruments for coronary and peripheral vascular diseases. The company's product portfolio includes balloon angioplasty catheters and microcatheters, sold in over 70 countries. Its strong market position is supported by proprietary technologies, such as its dual-therapy stent platform, and extensive global regulatory approvals.
| Price | $0.53 |
| Market Cap | $444M |
| P/E (TTM) | 10.65 |
| P/E (Forward) | 9.36 |
| Price/Book | 1.08 |
| Return on Equity | 10.4% |
| Return on Invested Capital | 11.3% |
| Debt/Equity | 0.94 |
| Gross Margin | 67.8% |
| Operating Margin | 24.4% |
| Revenue Growth | 13.8% |
| Dividend Yield | 2.8% |
| Free Cash Flow | $-59K |
OrbusNeich Medical Group Holdings Limited operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Hong Kong).